Eliglustat-d15
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Eliglustat-d15 Product Information
Eliglustat-d15 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-101435.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Eliglustat-d15
CAT No.
CS-T-101435
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C23H21D15N2O4
Molecular Weight
419.64
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Eliglustat-d15 is supplied with detailed characterization data compliant with regulatory guideline. Eliglustat-d15 can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
"Isotope labelled Eliglustat, which functions as an oral agent for treatment of Gaucher disease type 1, and lysosomal storage disorders in human. It also inhibits UDP-glucosylceramide synthase in mice thereby preventing Gaucher disease-associated with B-cell malignancy."
Synonyms
Eliglustat-d15
Application Notes
"Isotope labelled Eliglustat, which functions as an oral agent for treatment of Gaucher disease type 1, and lysosomal storage disorders in human. It also inhibits UDP-glucosylceramide synthase in mice thereby preventing Gaucher disease-associated with B-cell malignancy."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.